Niki BioSolutions NIKI
NASDAQ NIKI
$1.94 -0.06 (-3.00%)
As of: Oct 22, 2026 · 2:46 PM EDT

Niki BioSolutions (NIKI) Cash from Operations (2024 - 2025)

Updated

Niki BioSolutions (NIKI) recorded Cash from Operations of -$409,955 in FY2025.

Analysis

Niki BioSolutions (NIKI) Cash from Operations (2024 - 2025) Analysis & Trends

Starting with FY2017, Niki BioSolutions' Cash from Operations history includes 9 years.

  • The FY2025 figure is the highest annual Cash from Operations in data going back to FY2017.
  • Per Business Quant data, NIKI's Cash from Operations was -$1.19 million in FY2024, -$7.72 million in FY2023, -$12.32 million in FY2022 and -$14.65 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 7.72 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.44 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.87 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.57 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 835.00 Mn
10 Niki BioSolutions 1.06 Mn 817,586.43 - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -171,585.00
Nov 30, 2024 -85,312.00
Aug 31, 2024 -60,549.00
API Access

Niki BioSolutions Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NIKI&period=max&api_key=YOUR_API_KEY